|| Print ||
|Articles - June 2010|
|Thursday, May 13, 2010|
Though it's true that Microsoft chairman Bill Gates met Richard Friesner, co-founder of the Portland-based scientific firm Schrödinger, while playing bridge, there's much more to Gates' recent $10 million investment in Schrödinger than a card game.
"That's something we can all smile about," says Shi-Yi Liu, vice president of marketing for Schrödinger, "but I think it's more fair to say that, as people get to know each other, there's a meeting of the minds and shared views about science and technology."
Founded in California in 1990 and relocated to Portland in 1995, Schrödinger specializes in pharmaceutical software that helps researchers simulate testing of drug compounds. The company, which tops the $20 million revenue mark, employs 140 people, including 40 in Portland.
Liu says the infusion, made through Gates' investment arm, Cascade Investment, will primarily help Schrödinger beef up its research and development staff. The end result: more accurate and better-performing software for new drug development.
Though some of the company's scientists are in Portland — along with the accounting, technical and scientific support and quality assurance departments — most research is done in Schrödinger's New York office, closer to scientific advisers and large commercial customers. That's likely to remain unchanged even with Gates' investment.
Because the drug development process can take more than 10 years and sometimes billions of dollars, Liu says there's not a specific drug that can yet be tied directly to Schrödinger. However, various companies have reached milestones in their drug development processes with Schrödinger's technology. Among its more well-known customers: Bayer HealthCare AG.
The Gates investment, Liu says, comes at an opportune time for Schrödinger and will ultimately provide researchers with more powerful tools in their search for new drugs. One such researcher: David Dawson, who is pursuing a cure for cystic fibrosis at Oregon Health & Science University.
"We're really making an investment in scientific research," Liu says. "We have many ambitious goals and we know where additional basic and advanced research efforts are needed. This investment will enable us to start to execute on that."
Wednesday, November 26, 2014
BY NISHANT BHAJARIA | OP-ED CONTRIBUTOR
By now, anyone who knows about it has a position on President Obama’s executive order on immigration. The executive order is the outcome of failed attempts at getting a bill through the normal legislative process. Both Obama and his predecessor came close, but not close enough since the process broke down multiple times.
Friday, October 31, 2014
BY LINDA BAKER | OB EDITOR
Why are there so few transportation startups in Portland? The city’s leadership in bike, transit and pedestrian transportation has been well-documented. But that was then — when government and nonprofits paved the way for a new, less auto centric way of life.
Wednesday, October 22, 2014
BY AMY MILSHTEIN
Meetings get a bad rap. A few local companies make them count.
Tuesday, October 14, 2014
BY JONATHAN FROCHTZWAJG
A flare-up in the Elliott Forest raises questions about détente in Oregon’s timber wars.
Thursday, October 02, 2014
More than 5,500 employees from 180 organizations throughout the state participated in the 100 Best Nonprofits to Work for in Oregon project.
Wednesday, October 15, 2014
BY DIANE BUISMAN
Some common misconceptions employers have about marijuana.
Monday, November 10, 2014
BY KIM MOORE | OB RESEARCH EDITOR
A market for low-carbon transportation fuels has a chance to flourish in Oregon if regulators adopt the second phase of the state’s Clean Fuels Program.
|A Complex Portrait: Immigration, Jobs and the Economy|
|Woman of Steel|
|Kill the Meeting|
|Ferguson bakery saved by crowdfunding|
|Obamacare yields more than 1M applicants in first week of open enrollment|
|Price of already-built homes in Seattle area drops|
|Apple hits record-high value|
|Fed's ability to regulate questioned|
|Budweiser to move away from Clydesdales|
|Mergers lucrative for departing CEOs, but not necessarily shareholders|
Is your business ready to join us in the call for action? This opening panel includes Oregon businesses who will discuss why they signed the Oregon Climate Declaration, the investments they are making to reduce carbon emissions, and how their actions are affecting their companies.
Get ready for two days of special events produced with the EPA, Portland Timbers and ISOS before and after the GoGreen Conference on October 16.
Plenty of employers seem “dazed and confused” after the recent vote to legalize marijuana. In light of Measure 91 passing, what are some issues for private-sector Oregon employers to consider?
Rotary’s Oregon Ethics in Business aims to raise consciousness about business ethics by honoring exceptional companies.
Barran Liebman’s annual employment law seminar is an industry classic.
Is my drug-free workplace policy up in smoke?
More than 400 "Change Makers" will gather to invest in a socially sustainable community.